Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.
about
Stem cell transplantation for primary immunodeficiency diseases: the North American experienceUnbalanced Immune System: Immunodeficiencies and AutoimmunityFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesNewborn Screening for Severe Combined Immunodeficiency; The Wisconsin Experience (2008–2011)A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.Advances in basic and clinical immunology in 2009A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Warts and all: human papillomavirus in primary immunodeficiencies.Combined immunodeficiency in the United States and Kuwait: Comparison of patients' characteristics and molecular diagnosis.Screening for severe combined immunodeficiency in neonates.Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency.FOXN1 deficient nude severe combined immunodeficiency.Primary Immune Deficiency Treatment Consortium (PIDTC) report.Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.Vaccinations in juvenile chronic inflammatory diseases: an update.ICON: the early diagnosis of congenital immunodeficiencies.Severe combined immunodeficiency: recent developments and guidance on clinical management.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.Primary Immune Deficiency Treatment Consortium (PIDTC) update.The Primary Immune Deficiency Treatment Consortium: how can it improve definitive therapy for PID?Clinical and imaging considerations in primary immunodeficiency disorders: an update.An Update on the Use of Immunomodulators in Primary Immunodeficiencies.Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumSignificant changes in the composition of the precursor B-cell compartment in children less than 2 years old.The effects of prenatal genetic analysis on fetuses born to carrier mothers with primary immunodeficiency diseases.Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay.Newborn screening for SCID: three years of experience.Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.Immunological Emergency in Neonate: Case Report and Role of Early Screening.
P2860
Q26827162-EB4D1CD9-7934-4976-84C5-EFC0E76DBB87Q28075911-F5B9FD90-ACC8-4E54-BD44-2C77EFE4E17DQ28076919-A1DFFE6F-EA9C-4B2A-B5A8-897CBBBC2204Q29400676-7CAF6489-3E1A-4D8A-901C-610579BC98E7Q33627439-A623C188-25E8-40C4-BA13-6EB925FC8323Q33737600-FF375B15-7A0C-44DA-B5BC-FF354DE568D7Q34052889-F731E1F0-12FE-4654-96D2-9A9DFE5CEFCAQ34147585-AE464E38-90DB-4C08-A670-1958C0CEEC88Q34294647-052072C7-1830-4542-95A1-04AE56E18717Q34343785-9C5CE9B2-810D-4BC5-AB40-905E5E3D85BEQ36455030-E3756499-0A5B-4E44-B4BF-5567877A7944Q36908611-2857FB53-B821-44F7-8B76-D2148E796117Q37196045-659C9964-C8B1-4EC0-97C6-1972D803850CQ37238684-79AB156E-66A8-4D13-AB4B-6C06C7E0C3ECQ37356266-0CBD8016-D1C8-47A6-97C7-F4B09A628858Q37579202-3911C7BD-B398-46D0-B417-34179B162085Q37649782-FBDCA208-56BA-41A5-8A27-A2AC7D2A53CCQ37678465-4C23E979-27C1-4DE1-A75E-B3F212806804Q38118893-4766B76A-9C4C-4287-996F-C6F452DB8291Q38195246-35D1AED9-45FB-495E-9880-78781DFAF76DQ38309572-1816EF89-4B7A-4207-86E6-E772DD1B1B83Q38405199-7580F01E-3DEC-4DB4-9873-24ED76BDF9B1Q38420971-31AFA8C6-CD54-4527-A26C-6145AABD7B5EQ38855061-7FD68163-AD0F-44AB-93BA-7EDDFF072149Q38907589-AE1346A5-68D0-487F-A03A-B88D2DAA0372Q38961320-F24E7A99-BCFB-4010-852A-D388149A79BDQ39016299-47F2D174-00B9-4B17-92C8-2D611F214AC9Q39289010-378DCF72-CC22-47D4-A845-717EB68DF209Q39454415-514EEDAB-AD90-4D59-9C87-E899C82309EFQ40800083-41805294-9037-46B3-8897-B6E09C44C986Q42602801-5CB98EB9-266D-4ECD-9CB7-F6A3064AE013Q46651963-AD630856-6CE1-4866-B064-77E3977200EBQ47131379-D2264EFA-D5FC-4C46-90DF-4DEDBB16DA17Q51485505-25C393FA-94CC-401E-8C5B-0ECCBD47891AQ54624587-84A04C32-BEB8-4FDD-B6AE-E0A7F4B84CB5Q55360984-0D7143A2-C329-46AA-8787-C768F2EF3042
P2860
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Improving cellular therapy for ...... on, diagnosis, and management.
@ast
Improving cellular therapy for ...... on, diagnosis, and management.
@en
type
label
Improving cellular therapy for ...... on, diagnosis, and management.
@ast
Improving cellular therapy for ...... on, diagnosis, and management.
@en
prefLabel
Improving cellular therapy for ...... on, diagnosis, and management.
@ast
Improving cellular therapy for ...... on, diagnosis, and management.
@en
P2093
P2860
P1476
Improving cellular therapy for ...... on, diagnosis, and management.
@en
P2093
Chaim M Roifman
Fabio Candotti
H Bobby Gaspar
Hans D Ochs
J Douglas Rizzo
Jennifer M Puck
Linda M Griffith
Luigi D Notarangelo
Mary Ellen Conley
Morton J Cowan
P2860
P304
1152-60.e12
P356
10.1016/J.JACI.2009.10.022
P407
P577
2009-12-01T00:00:00Z